Overview
Ryohei Ohtani practices in Chiba, Japan. Ohtani is rated as an Advanced expert by MediFind in the treatment of Multiple Sclerosis (MS). Their top areas of expertise are Transverse Myelitis, Neuromyelitis Optica, Optic Neuritis, and Multiple Sclerosis (MS).
Their clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Multiple Sclerosis (MS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Neuromyelitis OpticaOhtani isDistinguished. Learn about Neuromyelitis Optica.
- Optic NeuritisOhtani isDistinguished. Learn about Optic Neuritis.
- Transverse MyelitisOhtani isDistinguished. Learn about Transverse Myelitis.
- Advanced
- Multiple Sclerosis (MS)Ohtani isAdvanced. Learn about Multiple Sclerosis (MS).
- Experienced
- Brain TumorOhtani isExperienced. Learn about Brain Tumor.
- CACH SyndromeOhtani isExperienced. Learn about CACH Syndrome.
- EncephalitisOhtani isExperienced. Learn about Encephalitis.
- MyelitisOhtani isExperienced. Learn about Myelitis.
- Relapsing Multiple Sclerosis (RMS)